Chronic pain and opioid abuse: Factors associated with health‐related quality of life

Jones, Jermaine D.; Vogelman, Jonathan S.; Luba, Rachel; Mumtaz, Mudassir; Comer, Sandra D.

doi:10.1111/ajad.12637

Cited by 27 publications

(26 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Muñoz et al 23 reported that the clinical manifestations of pain in old age are different from those commonly observed in younger patients. This observation corroborates previous reports that indicate that aging individuals appear to be less sensitive to painful stimuli in the sensory dimension, because the old age reduces pain in all areas, except for the joints 24 .…”

Section: Discussionsupporting

confidence: 92%

Associação de dor crônica com força, níveis de estresse, sono e qualidade de vida em mulheres acima de 50 anos

et al. 2019

View full text Add to dashboard Cite

RESUMO A literatura apresenta a necessidade de investigar as dores osteoarticulares crônicas em idosos, uma vez que essas influenciam negativamente parâmetros biopsicossociais. Entender a relação entre as dimensões da dor e parâmetros de saúde dos indivíduos acometidos é necessário para melhor abordagem preventiva e terapêutica. Este trabalho tem o objetivo de identificar relações entre níveis de dores crônicas e força, qualidade de vida, estresse e sono em mulheres (as mais acometidas pelas dores osteoarticulares crônicas). Foram recrutadas participantes de um programa de educação física para idosos, com idade entre 50 e 70 anos. A dor foi avaliada por meio de um instrumento multidimensional. Foram avaliados também estado cognitivo global, nível de atividade física, qualidade de vida, estresse e sono. A força muscular das participantes foi analisada por meio do teste de sentar e levantar e do teste de flexão e extensão de cotovelo. Participaram 56 mulheres, com média de idade de 63,7±7,7 anos, e 28,7±4,7kg/m2 de índice de massa corporal (IMC). A maior parte das participantes relatou sentir dor (89,2%); 21,4% relataram dor nos membros inferiores e 67,8% relataram dor nos membros superiores. A dimensão sensorial de dor foi associada ao estresse, mas não às demais variáveis, que não se relacionaram a nenhum dos aspectos da dor. Além disso, pode haver influência da idade na interpretação da dor avaliativa.

show abstract

Section: Discussionsupporting

confidence: 92%

Associação de dor crônica com força, níveis de estresse, sono e qualidade de vida em mulheres acima de 50 anos

et al. 2019

View full text Add to dashboard Cite

show abstract

“…Although chronic opioid use itself is not a traditional QOL indicator, it is certainly closely associated with chronic pain and discomfort. Accordingly, research has demonstrated that both opioid dependence and chronic pain both decrease patients' health‐related QOL . An important consideration is that many patients receive adjuvant RT or CRT postoperatively based on high‐risk pathologic features.…”

Section: Discussionmentioning

confidence: 99%

Effect of treatment modality on chronic opioid use in patients with T1/T2 oropharyngeal cancer

Bollig

Jorgensen

2019

Head & Neck

View full text Add to dashboard Cite

Background The effect of treatment modality on long‐term opioid dependence in patients with oropharyngeal cancer has not been reported. Methods A retrospective cohort of 122 patients with T1/T2 oropharyngeal cancer undergoing treatment was generated. Risk factors associated with chronic opioid use were investigated by univariate and multivariate analyses. Results The prevalence of chronic opioid use was 45.9%. On multivariate analysis, primary nonsurgical treatment (odds ratio [OR] 4.5, 95% confidence interval [CI]: 1.7‐11.4), pretreatment opioid use (OR 14.9, 95% CI: 3.5‐62.5), psychiatric disorder (OR 4.3, 95% CI: 1.03‐18.5), alcohol use (OR 2.6, 95% CI: 1.03‐6.5), and younger age (OR 1.1, 95% CI: 1.02‐1.11) were significantly associated with chronic opioid use. Conclusion Primary nonsurgical treatment, younger age, pretreatment opioid use, alcohol use, and psychiatric disorder were independently associated with an increased risk of chronic opioid use. Preventative strategies should be especially focused toward these patients to reduce their risk of long‐term opioid use.

show abstract

“…In some health care environments, process measures can be assessed in real time as they occur through electronic health records. Finally, outcome measures, which often require risk adjustment based on patient characteristics for comparative purposes, typically refer to patients’ clinical outcomes, such as the percentage of OUD patients initiating buprenorphine with subsequent opioid negative urines or with clinically meaningful improvements in health and quality of life (Bray et al, 2017; Jones, Vogelman, Luba, Mumtaz, & Comer, 2017). …”

Section: Methodsmentioning

confidence: 99%

Developing an opioid use disorder treatment cascade: A review of quality measures

Williams

Nunes

Bisaga

et al. 2018

Journal of Substance Abuse Treatment

123

View full text Add to dashboard Cite

Background Despite increasing opioid overdose mortality, problems persist in the availability and quality of treatment for opioid use disorder (OUD). Three FDA-approved medications (methadone, buprenorphine, and naltrexone) have high quality evidence supporting their use, but most individuals with OUD do not receive them and many experience relapse following care episodes. Developing and organizing quality measures under a unified framework such as a Cascade of Care could improve system level practice and treatment outcomes. In this context, a review was performed of existing quality measures relevant to the treatment of OUD and the literature assessing the utility of these measures in community practice. Methods Systematic searches of two national quality measure clearinghouses (National Quality Forum and Agency for Healthcare Research and Quality) were performed for measures that can be applied to the treatment of OUD. Measures were categorized as structural, process, or outcome measures. Second stage searches were then performed within Ovid/Medline focused on published studies investigating the feasibility, reliability, and validity of identified measures, predictors of their satisfaction, and related clinical outcomes. Results Seven quality measures were identified that are applicable to the treatment of OUD. All seven were process measures that assess patterns of service delivery. One recently approved measure addresses retention in medication-assisted treatment for patients with OUD. Twenty-nine published studies were identified that evaluate the quality measures, primarily focused on initiation and engagement in care for addiction treatment generally. Most measures and related studies do not specifically incorporate the evidence base for the treatment of OUD or assess patient level outcomes such as overdose. Conclusion Despite considerable progress, gaps exist in quality measures for OUD treatment. Development of a unified quality measurement framework such as an OUD Treatment Cascade will require further elaboration and refinement of existing measures across populations and settings. Such a framework could form the basis for applying strategies at clinical, organizational, and policy levels to expand access to quality care and reduce opioid-related mortality.

show abstract

Chronic pain and opioid abuse: Factors associated with health‐related quality of life

Cited by 27 publications

References 39 publications

Associação de dor crônica com força, níveis de estresse, sono e qualidade de vida em mulheres acima de 50 anos

Associação de dor crônica com força, níveis de estresse, sono e qualidade de vida em mulheres acima de 50 anos

Effect of treatment modality on chronic opioid use in patients with T1/T2 oropharyngeal cancer

Developing an opioid use disorder treatment cascade: A review of quality measures

Contact Info

Product

Resources

About